Information de reference pour ce titreAccession Number: | 00001774-200608000-00007.
|
Author: | Garnett, M. C.; Kallinteri, P.
|
Institution: | School of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, UK
|
Title: | Nanomedicines and nanotoxicology: some physiological principles.[Review]
|
Source: | Occupational Medicine (Oxford). 56(5):307-311, August 2006.
|
Abstract: | Nanosized materials have been investigated as potential medicines for several decades. Consequently, a great deal of work has been conducted on how to exploit constructs of this size range in a beneficial way. Similarly, a number of the consequences from the use of these materials have already been considered. Nanosized materials do behave differently to low-molecular-weight drugs, the biological properties of nanomaterials being mainly dependent on relevant physiology and anatomy, which are reviewed in this article. Biodistribution, movement of materials through tissues, phagocytosis, opsonization and endocytosis of nanosized materials are all likely to have an impact on potential toxicity. In turn these processes are most likely to depend on the nanoparticle surface. Evidence from the literature is considered which suggests that our understanding of these areas is incomplete, and that biodistribution to specific sites can occur for nanoparticles with particular characteristics. However, our current knowledge does indicate which areas are of concern and deserve further investigation to understand how individual nanoparticles behave and what toxicity may be expected from them.
(C) Society of Occupational Medicine 2006. Published by Oxford University Press. All rights reserved.
|
Author Keywords: | Biodistribution; nanomedicines; nanoparticles; physiological barriers; toxicology.
|
References: | 1. Stolnik S, Illum L, Davis SS. Long circulating microparticulate drug carriers. Adv Drug Deliv Rev 1995;16:195-214.
2. Schnitzer JE. Caveolae: from basic trafficking mechanisms to targeting transcytosis for tissue specific drug and gene delivery in vivo. Adv Drug Deliv Rev 2001;49:265-280.
3. Maeda H, Matsumura Y. Tumoritropic and lymphotropic principles of macromolecular drugs. Crit Rev Ther Drug Carrier Syst 1989;6:193-210.
4. Van Deurs B, Peterson OW, Olsnes S, Sandvig K. The ways of endocytosis. Int Rev Cytol 1989;117:131-177.
5. Porter CJ, Moghimi SM, Illum L, Davis SS. The polyoxyethylene/polyoxypropylene block copolymer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow. FEBS Lett 1992;305:63-66.
6. Kruth HS, Chang J, Ifrim I, Zhang W-Y. Characterisation of patocytosis: endocytosis into macrophage surface-connected compartments. Eur J Cell Biol 1999;78:91-99.
7. Geiser M, Rothe-Rutishauser B, Kapp N et al. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 2005;113:1555-1560.
8. Hong S, Bielinska AU, Mecke A et al. Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport. Bioconjug Chem 2004;15:774-782.
9. Kreuter J. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 2001;47:65-81.
10. Lind K, Kresse M, Debus NP, Muller RH. A novel formulation for superparamagnetic iron oxide (SPIO) particle enhancing MR lymphography: comparison of physicochemical properties and the in vivo behaviour. J Drug Target 2002;10:221-230.
11. Hawley AE, Davis SS, Illum L. Targeting of colloids to lymph nodes: influence of lymphatic physiology and colloidal characteristics. Adv Drug Deliv Rev 1995;17:129-148.
12. Brightman MW. The distribution within the brain of ferritin injected into cerebrospinal fluid compartments. II. Parenchymal distribution. Am J Anat 1966;117:193-220.
13. Kallinteri P, Higgins S, Hutcheon GA, St Pourcain CB, Garnett MC. Novel functionalized biodegradable polymers for nanoparticle drug delivery systems. Biomacromolecules 2005;6:1885-1894.
14. Villodi A. Lysosomal storage disorders. Br J Haematol 2004;128:413-431.
|
Language: | English.
|
Document Type: | In-depth Review.
|
Journal Subset: | Clinical Medicine. Behavioral & Social Sciences.
|
ISSN: | 0962-7480
|
NLM Journal Code: | a79, 9205857
|
Annotation(s) | |